Registered entities
Nodthera Limited
Reg. No. SC540381United Kingdom
Innovation
20 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 1,888 times.
| Year | Filings |
|---|---|
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 8 |
| 2021 | 3 |
| 2022 | 7 |
| 2023 | 7 |
| 2024 | 7 |
| 2025 | 13 |
| 2026 | 3 |
Social engagement
Social engagement: 6K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
8 investors on record; lead investors include Novo Holdings, 5AM Ventures, Sofinnova Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 75% |
| Bank & private debt | 1 | 13% |
| Other / undisclosed | 1 | 13% |
Hiring activity
Hires occasionally
2 roles tracked across 2 of the last 12 months
8 Apr 2026 · General Counsel
24 Mar 2026 · Director of Financial Planning & Analysis · Boston area
Based on job postings tracked across public sources.
Recent activity
2 Jun 2026
Event
2nd Annual Obesity & Cardiometabolic Innovation Forum
21 May 2026
Event
European Atherosclerosis Society Congress 2026
19 May 2026
Event
European Atherosclerosis Society (EAS) Congress 2026